| Patent | Date |
|---|
Materials And Methods For Modulating An Immune Response
App 20220306739 - Ganesan; Rajkumar ; et al. | 2022-09-29 |
Chimeric Antigen Receptor System And Uses Thereof
App 20220305056 - GANESAN; Rajkumar ; et al. | 2022-09-29 |
Antibody Targeting Cd22 And Cd79b
App 20220306738 - Bednar; Kyle J. ; et al. | 2022-09-29 |
Treatment of Cancers Lacking EGFR- Activating Mutations
App 20220298248 - Henley; Benjamin ; et al. | 2022-09-22 |
Substituted Urea Dihydroorotate Dehydrogenase Inhibitors
App 20220298107 - Kuduk; Scott ; et al. | 2022-09-22 |
Methods For Lowering Blood Glucose
App 20220296653 - Xu; Jean | 2022-09-22 |
Safe and Effective Method of Treating Psoriatic Arthritis with Anti-IL23 Specific Antibody
App 20220298236 - Hsia; Elizabeth ; et al. | 2022-09-22 |
Dihydroorotate Dehydrogenase Inhibitors
App 20220298137 - Kuduk; Scott ; et al. | 2022-09-22 |
Pharmaceutical package
Grant D964,171 - Gysel , et al. September 20, 2 | 2022-09-20 |
PD-L1 binding fibronectin type III domains
Grant 11,447,539 - Diem , et al. September 20, 2 | 2022-09-20 |
Methods for Predicting Treatment Response in Ulcerative Colitis
App 20220291238 - Li; Xilin ; et al. | 2022-09-15 |
Tissue Anchor And Related Methods
App 20220287702 - DAGLOW; Terry | 2022-09-15 |
Method of Treating Psoriatic Arthritis Patients with Inadequate Response to TNF Therapy with Anti-IL23 Specific Antibody
App 20220289834 - Hsia; Elizabeth C. ; et al. | 2022-09-15 |
Safe And Effective Method Of Treating Psoriasis With Anti-il-23 Specific Antibody
App 20220289835 - Angsana; Julianty ; et al. | 2022-09-15 |
Optimized Culture Media For Clostridia Bacteria
App 20220282206 - Bodek; John ; et al. | 2022-09-08 |
Differentiation Of Human Embryonic Stem Cells Into Single Hormonal Insulin Positive Cells
App 20220275340 - Rezania; Alireza | 2022-09-01 |
Use of Approved Anti-CD38 Antibody Drug Product to Treat Light Chain Amyloidosis
App 20220275101 - Schecter; Jordan | 2022-09-01 |
Combination Therapies with Anti-CD38 Antibodies and PARP or Adenosine Receptor Inhibitors
App 20220275090 - Alvarez Arias; Diana | 2022-09-01 |
Materials And Methods For Targeting Regulatory T Cells For Enhancing Immune Surveillance
App 20220267456 - GREWAL; Iqbal S. ; et al. | 2022-08-25 |
Bcma-targeted Car-t Cell Therapy For Multiple Myeloma
App 20220265710 - SCHECTER; Jordan Mark ; et al. | 2022-08-25 |
Lipase Degradation Resistant Surfactants for Use in Large Molecule Therapeutic Formulations
App 20220265596 - LaBrenz; Steven ; et al. | 2022-08-25 |
Materials And Methods For Enhanced Linker Targeting
App 20220267472 - SINGH; Sanjaya ; et al. | 2022-08-25 |
Nucleic acids encoding anti-CD154 antibodies
Grant 11,421,037 - Fransson , et al. August 23, 2 | 2022-08-23 |
Cd137 Binding Fibronectin Type Iii Domains
App 20220259289 - Diem; Michael ; et al. | 2022-08-18 |
Fcrn Antibodies And Methods Of Use Thereof
App 20220259308 - ARROYO; Santiago ; et al. | 2022-08-18 |
Anti-CCL17 antibodies
Grant 11,414,484 - Boakye , et al. August 16, 2 | 2022-08-16 |
Low Temperature Vials And Vial Assemblies
App 20220226191 - Folta; Christopher M. ; et al. | 2022-07-21 |
Arthritis treatment
Grant 11,390,672 - Simard July 19, 2 | 2022-07-19 |
Antibody Formulation
App 20220220196 - SIMARD; John | 2022-07-14 |
Sialylated Glycoproteins
App 20220211849 - Patil; Siddhesh D. | 2022-07-07 |
Differentiation of human embryonic stem cells into single hormonal insulin positive cells
Grant 11,377,640 - Rezania July 5, 2 | 2022-07-05 |
Novel Formulations Which Stabilize Low Dose Antibody Compositions
App 20220202937 - Mackay; Joanna | 2022-06-30 |
Combination Therapies Comprising Daratumumab, Bortezomib, Thalidomide and Dexamethasone and Their Uses
App 20220204638 - Liu; Xiangyang ; et al. | 2022-06-30 |
Methods for lowering blood glucose
Grant 11,369,642 - Xu June 28, 2 | 2022-06-28 |
Neoantigen Peptide Mimics
App 20220194999 - Krishna; Vinod ; et al. | 2022-06-23 |
Anti-TNF Antibodies, Compositions, and Methods for the Treatment of Active Ankylosing Spondylitis
App 20220195028 - Harrison; Diane D. ; et al. | 2022-06-23 |
Anti-PHF-tau antibodies and uses thereof
Grant 11,365,244 - Mercken , et al. June 21, 2 | 2022-06-21 |
FC engineered anti-TNFR superfamily member antibodies having enhanced agonistic activity and methods of using them
Grant 11,359,029 - Chiu , et al. June 14, 2 | 2022-06-14 |
Methods of Engineering Surface Charge for Bispecific Antibody Production
App 20220169741 - Nesspor; Thomas | 2022-06-02 |
CD137 binding fibronectin type III domains
Grant 11,345,739 - Diem , et al. May 31, 2 | 2022-05-31 |
Manufacturing Methods for Producing Anti-TNF Antibody Compositions
App 20220153830 - Barnthouse; Kristopher ; et al. | 2022-05-19 |
Methods for Producing Anti-TNF Antibody Compositions
App 20220153829 - Barnthouse; Kristopher ; et al. | 2022-05-19 |
Anti-TNF Antibody Compositions and Methods for the Treatment of Juvenile Idiopathic Arthritis
App 20220153827 - Bensley; Karen ; et al. | 2022-05-19 |
Macrocyclic Compounds And Methods Of Use Thereof
App 20220143231 - Salter; Rhys ; et al. | 2022-05-12 |
Methods for Producing Anti-TNF Antibody Compositions
App 20220144934 - Barnthouse; Kristopher ; et al. | 2022-05-12 |
Fcrn Antibodies And Methods Of Use Thereof
App 20220144946 - Ramchandran; Sindhu ; et al. | 2022-05-12 |
Cryogenic Storage Transportation Tracking System
App 20220138676 - Hutchinson; Michael ; et al. | 2022-05-05 |
Par2 Modulation And Methods Thereof
App 20220125898 - LIU; Changlu ; et al. | 2022-04-28 |
Compositions And Methods For Modulating Delta Gamma Chain Mediated Immunity
App 20220125947 - GANESAN; Rajkumar ; et al. | 2022-04-28 |
Anti-vbeta17/anti-cd123 Bispecific Antibodies
App 20220127359 - GANESAN; Rajkumar ; et al. | 2022-04-28 |
Antigen Binding Regions Against Fibronectin Type III Domains and Methods of Using the Same
App 20220127343 - Huang; Chichi ; et al. | 2022-04-28 |
Treatment Of Hidradenitis Suppurativa
App 20220127353 - GIAMARELLOS-BOURBOULIS; Evangelos J. ; et al. | 2022-04-28 |
Therapeutic Agents And Uses Thereof
App 20220125961 - Strand; Sven-Erik ; et al. | 2022-04-28 |
Pharmaceutical package
Grant D949,018 - Gysel , et al. April 19, 2 | 2022-04-19 |
Method for Treating Crohn's Disease with Anti-IL12/IL23 Antibody
App 20220112282 - Lavie; Frederic ; et al. | 2022-04-14 |
Formulation Of A Pan-jak Inhibitor
App 20220112220 - Nitert; Bernardus Joseph ; et al. | 2022-04-14 |
Processes For Preparing A Pan-jak Inhibitor And Related Intermediate Compounds
App 20220112219 - Kraut; Norbert ; et al. | 2022-04-14 |
Biosynthetic Materials And Methods For Multidirectional Biotransportation
App 20220112276 - HARVILLA; Paul B. ; et al. | 2022-04-14 |
Bioengineered T Cell Mediated Immunity, Materials And Other Methods For Modulating Cluster Of Differentiation Iv &/or Viii
App 20220112288 - GANESAN; Rajkumar ; et al. | 2022-04-14 |
CD8A-binding fibronectin type III domains
Grant 11,299,534 - Hawkins , et al. April 12, 2 | 2022-04-12 |
Anti-HLA-C antibodies and uses thereof
Grant 11,299,545 - Eberwine , et al. April 12, 2 | 2022-04-12 |
Multi-specific Immune Targeting Molecules And Uses Thereof
App 20220089737 - GANESAN; Rajkumar ; et al. | 2022-03-24 |
Transition Analysis Method For Chromatography Column Qualification
App 20220089716 - Randolph; Paul | 2022-03-24 |
Manufacturing Methods To Control C-Terminal Lysine, Galactose And Sialic Acid Content In Recombinant Proteins
App 20220089712 - Flikweert; Marcel ; et al. | 2022-03-24 |
Dihydroorotate Dehydrogenase Inhibitors
App 20220089568 - Cisar; Justin ; et al. | 2022-03-24 |
Immune Targeting Molecules And Uses Thereof
App 20220089736 - GREWAL; Iqbal S. ; et al. | 2022-03-24 |
Methods And Compositions For Modulating Beta Chain Mediated Immunity
App 20220089731 - GANESAN; Rajkumar ; et al. | 2022-03-24 |
Efficient Impurity Removal Using A Diafiltration Process
App 20220090140 - Ko; Hsu-Feng ; et al. | 2022-03-24 |
Dihydroorotate Dehydrogenase Inhibitors
App 20220081422 - Cisar; Justin ; et al. | 2022-03-17 |
Beta-Galactosidase Alpha Peptide as a Non-Antibiotic Selection Marker and Uses Thereof
App 20220073934 - Perry; William | 2022-03-10 |
Method of Treating Psoriasis in Pediatric Subjects with Anti-IL12/IL23 Antibody
App 20220073603 - Hsu; Ming-Chun ; et al. | 2022-03-10 |
Anti-idiotypic Antibodies Against Anti-gprc5d Antibodies
App 20220064284 - CHI; Ellen ; et al. | 2022-03-03 |
Methods of Treating Multiple Myeloma
App 20220062415 - Xie; Hong ; et al. | 2022-03-03 |
Anti-hk2 Chimeric Antigen Receptor (car)
App 20220064254 - BRITTINGHAM; Raymond ; et al. | 2022-03-03 |
Treatment Of Psychiatric Conditions
App 20220062413 - SIMARD; John | 2022-03-03 |
Treatment of Non-Small Cell Lung Cancer with EGFR Mutations
App 20220064306 - Knoblauch; Roland ; et al. | 2022-03-03 |
Humanised Anti Kallikrein-2 Antibody
App 20220064333 - Timmermand; Par Oskar Vilhelmsson ; et al. | 2022-03-03 |
Anti-idiotypic Antibodies Against Anti-klk2 Antibodies
App 20220064334 - AINEKULU; Zemeda ; et al. | 2022-03-03 |
Anti-TNF Antibody Compositions for Use in Methods for the Treatment of Psoriatic Arthritis
App 20220064278 - Harrison; Diane D. ; et al. | 2022-03-03 |
Stable Formulations Comprising A Bispecific EGFR/C-Met Antibody
App 20220064307 - Kupec; Jessica ; et al. | 2022-03-03 |
Anti-IL-23 Antibodies, Compositions, Methods and Uses
App 20220054634 - Benson; Jacquelne ; et al. | 2022-02-24 |
Protoxin-ii Variants And Methods Of Use Thereof
App 20220054590 - FLINSPACH; Mack ; et al. | 2022-02-24 |
Materials And Methods Of Using Engineered Ligands
App 20220056104 - ZWOLAK; Adam ; et al. | 2022-02-24 |
Glycoproteins With Anti-inflammatory Properties
App 20220056109 - Sarvaiya; Hetal ; et al. | 2022-02-24 |
Cell-based Assay For Determining The In Vitro Tumor Killing Activity Of Chimeric Antigen Expressing Immune Cells
App 20220057381 - WILLIAMS; J. KENDALL | 2022-02-24 |
Anti-IL-6 Antibody
App 20220048985 - Chen; Yan ; et al. | 2022-02-17 |
COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
App 20220049019 - Bosques; Carlos J. ; et al. | 2022-02-17 |
Materials And Methods For Producing Bioengineered Virus Specific Lymphocytes
App 20220040232 - GANESAN; Rajkumar ; et al. | 2022-02-10 |
Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses
App 20220041745 - Bandekar; Rajesh ; et al. | 2022-02-10 |
Formulations For Highly Purified Viral Particles
App 20220040305 - TOMKOWICZ; Brian E. ; et al. | 2022-02-10 |
Chimeric Antigen Receptors Comprising Bcma-specific Fibronectin Type Iii Domains And Uses Thereof
App 20220031822 - CHIN; Chen Ni ; et al. | 2022-02-03 |
COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
App 20220033499 - Bosques; Carlos J. ; et al. | 2022-02-03 |
Materials And Methods For Multidirectional Biotransportation In Virotherapeutics
App 20220033522 - GANESAN; Rajkumar ; et al. | 2022-02-03 |
Proteins Comprising Hla-g Antigen Binding Domains And Their Uses
App 20220033505 - Obermajer; Natasa ; et al. | 2022-02-03 |
Safe and Effective Method of Treating Psoriatic Arthritis with Anti-IL23 Specific Antibody
App 20220025035 - Hsia; Elizabeth ; et al. | 2022-01-27 |
Humanised anti kallikrein-2 antibody
Grant 11,230,609 - Timmermand , et al. January 25, 2 | 2022-01-25 |
Methods and Compositions for Clinical Evaluation of Therapeutic Agents
App 20220018829 - Lamouse-Smith; Esi Sama Natya ; et al. | 2022-01-20 |
Anti-IL6 Agent for Treating Coronavirus Infection
App 20220017614 - Boven; Katia ; et al. | 2022-01-20 |
Transition analysis method for chromatography column qualification
Grant 11,225,516 - Randolph January 18, 2 | 2022-01-18 |
Treatment of hidradenitis suppurativa
Grant 11,225,517 - Giamarellos-Bourboulis , et al. January 18, 2 | 2022-01-18 |
Engineered Fc constructs
Grant 11,220,531 - Bosques , et al. January 11, 2 | 2022-01-11 |
Methods And Compositions For Prediction Of Response To A Therapy Of An Inflammatory Bowel Disease
App 20220002805 - BARIBAUD; Frederic ; et al. | 2022-01-06 |
Methods Of Safe Administration Of An Irf5 Antisense Oligonucleotide
App 20220002726 - Devineni; Damayanthi ; et al. | 2022-01-06 |
Treating Vascular Disease And Complications Thereof
App 20210403548 - SIMARD; John | 2021-12-30 |
Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38
App 20210403592 - Ahmadi; Tahamtan ; et al. | 2021-12-30 |
Method of treating psoriasis with anti-IL23 specific antibody
Grant 11,208,474 - Fitzgerald , et al. December 28, 2 | 2021-12-28 |
GDF15 fusion proteins and uses thereof
Grant 11,208,464 - Armstrong , et al. December 28, 2 | 2021-12-28 |
GM-CSF variants and methods of use
Grant 11,208,450 - Rutkoski , et al. December 28, 2 | 2021-12-28 |
Materials And Methods For The Manufacture Of Pluripotent Stem Cells
App 20210395697 - GREWAL; Iqbal S. ; et al. | 2021-12-23 |
Daratumumab and Hyaluronidase for the Treatment of Multiple Myeloma
App 20210393775 - Qi; Ming | 2021-12-23 |
Bispecific EGFR/C-Met Antibodies
App 20210395373 - Chiu; Mark ; et al. | 2021-12-23 |
Site-specific conjugation of glycosylated monoclonal antibodies with transglutaminase
App 20210388085 - Dudkin; Vadim ; et al. | 2021-12-16 |
Method of treating psoriatic arthritis with increased interval dosing of anti-IL12/23 antibody
Grant 11,197,913 - Chevrier , et al. December 14, 2 | 2021-12-14 |
Treatment of psychiatric conditions
Grant 11,191,831 - Simard December 7, 2 | 2021-12-07 |
Methods of engineering surface charge for bispecific antibody production
Grant 11,192,951 - Nesspor December 7, 2 | 2021-12-07 |
Anti-IL-23 antibodies, compositions, methods and uses
Grant 11,185,584 - Benson , et al. November 30, 2 | 2021-11-30 |
Compositions Comprising A T Cell Redirection Therapeutic And A Vla-4 Adhesion Pathway Inhibitor
App 20210363252 - Nair-Gupta; Priyanka ; et al. | 2021-11-25 |
Protoxin-ii Variants And Methods Of Use
App 20210363204 - FLINSPACH; Mack ; et al. | 2021-11-25 |
Safe and Effective Method of Treating Psoriatic Arthritis with Anti-IL23 Specific Antibody
App 20210363235 - Hsia; Elizabeth ; et al. | 2021-11-25 |
Method of Treating Inflammatory Bowel Disease with a Combination Therapy of Antibodies to IL-23 and TNF Alpha
App 20210363234 - Germinaro; Mathew ; et al. | 2021-11-25 |
METHODS FOR SITE SPECIFIC CONJUGATION OF PROTEINS CONTAINING GLYCOSYLATED Fc DOMAINS
App 20210363177 - Dudkin; Vadim ; et al. | 2021-11-25 |
Methods of suppressing rheumatoid arthritis using an anti-IL-6 antibody
Grant 11,180,549 - Chen , et al. November 23, 2 | 2021-11-23 |
Gamma Delta T Cells And Uses Thereof
App 20210355442 - GANESAN; Rajkumar ; et al. | 2021-11-18 |
Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody
App 20210347880 - Adedokun; Omoniyi ; et al. | 2021-11-11 |
Materials and Methods for Treating Juvenile Idiopathic Arthritis
App 20210340245 - Bensley; Karen ; et al. | 2021-11-04 |
Methods Of Treating Multiple Myeloma
App 20210338766 - Klippel; Zandra | 2021-11-04 |
Antigen binding regions against fibronectin type III domains and methods of using the same
Grant 11,161,897 - Huang , et al. November 2, 2 | 2021-11-02 |
Neurologic Toxicity Assessement Methods And Systems For Documenting Changes In Handwriting
App 20210330254 - DE BRAGANCA; Kevin C. ; et al. | 2021-10-28 |
Chromatography Column Qualification In Manufacturing Methods For Producing Anti-il12/il23 Antibody Compositions
App 20210332124 - Randolph; Paul | 2021-10-28 |
Compositions and methods related to engineered Fc constructs
Grant 11,155,640 - Bosques , et al. October 26, 2 | 2021-10-26 |
Injection Training Device And Method For Using Same
App 20210327302 - Vesole; Steven ; et al. | 2021-10-21 |
Pharmaceutical Composition For Oral Administration Comprising Aminopyrimidine Derivative Or Pharmaceutically Acceptable Salt, Hydrate, Or Solvate Thereof
App 20210322323 - Maximilien; Jacqueline ; et al. | 2021-10-21 |
Manufacturing methods to control C-terminal lysine, galactose and sialic acid content in recombinant proteins
Grant 11,149,085 - Flikweert , et al. October 19, 2 | 2021-10-19 |
Engineered multispecific antibodies and other multimeric proteins with asymmetrical CH2-CH3 region mutations
Grant 11,149,094 - Chiu , et al. October 19, 2 | 2021-10-19 |
Psma And Steap1 Vaccines And Their Uses
App 20210315986 - Gottardis; Marco ; et al. | 2021-10-14 |
Materials and Methods for Improved Prediction of IGG Therapeutic Protein Exposure
App 20210318334 - Chen; Yang ; et al. | 2021-10-14 |
Method Of Providing Safe Administration Of An Anti-cd154 Antibody
App 20210317220 - RIGBY; Mark ; et al. | 2021-10-14 |
Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody
App 20210308220 - Adedokun; Omoniyi ; et al. | 2021-10-07 |
Substituted quinazoline and quinazolinone compounds and methods of use thereof
Grant 11,136,308 - Li , et al. October 5, 2 | 2021-10-05 |
Cysteine Engineered Fibronectin Type Iii Domain Binding Molecules
App 20210301025 - GOLDBERG; Shalom ; et al. | 2021-09-30 |
Compositions and methods related to engineered Fc constructs
Grant 11,124,573 - Bosques , et al. September 21, 2 | 2021-09-21 |
Method for treating pre-type 1 diabetes in a human subject
Grant 11,124,565 - Hedrick , et al. September 21, 2 | 2021-09-21 |
Methods And Materials For Modulating An Immune Response
App 20210284731 - Ganesan; Rajkumar ; et al. | 2021-09-16 |
Materials And Methods For Modulating Delta Chain Mediated Immunity
App 20210284730 - Ganesan; Rajkumar ; et al. | 2021-09-16 |
Anti-tnf Antibodies, Compositions, And Methods For The Treatment Of Active Ankylosing Spondylitis
App 20210277104 - Harrison; Diane D. ; et al. | 2021-09-09 |
Antibodies Specifically Binding Pd-1, Tim-3 Or Pd-1 And Tim-3 And Their Uses
App 20210277110 - Verona; Raluca ; et al. | 2021-09-09 |
Cyclic Dinucleotides As Sting Agonists
App 20210277046 - Emanuel; Stuart ; et al. | 2021-09-09 |
Compositions and methods for antibodies targeting staphylococcal leukotoxins
Grant 11,104,724 - Torres , et al. August 31, 2 | 2021-08-31 |
Neoantigens Expressed In Ovarian Cancer And Their Uses
App 20210261609 - BHARGAVA; Vipul ; et al. | 2021-08-26 |
Peptide Inhibitors Of Interleukin-23 Receptor And Their Use To Treat Inflammatory Diseases
App 20210261622 - Sun; Chengzao ; et al. | 2021-08-26 |
Neoantigens Expressed In Multiple Myeloma And Their Uses
App 20210261636 - BHARGAVA; Vipul ; et al. | 2021-08-26 |
Chimeric antigen receptors comprising BCMA-specific fibronectin type III domains and uses thereof
Grant 11,096,998 - Chin , et al. August 24, 2 | 2021-08-24 |
Safe and Effective Method of Treating Ulcerative Colitis with Anti-IL12/IL23 Antibody
App 20210253690 - Johanns; Jewel ; et al. | 2021-08-19 |
Treatment of Patients Having c-Met Exon 14 Skipping Mutations
App 20210253717 - Knoblauch; Roland ; et al. | 2021-08-19 |
Protoxin-II variants and methods of use
Grant 11,083,776 - Flinspach , et al. August 10, 2 | 2021-08-10 |
Treatment Of Atopic Dermatitis
App 20210238273 - Simard; John | 2021-08-05 |
Anti-tnf Antibodies, Compositions, And Methods For The Treatment Of Active Ankylosing Spondylitis
App 20210238271 - Harrison; Diane D. ; et al. | 2021-08-05 |
Method for treating lupus by administering an anti-IL-12 antibody
Grant 11,078,267 - Giles-Komar , et al. August 3, 2 | 2021-08-03 |
Fc .gamma. RIII binding fibronectin type III domains, their conjugates and multispecific molecules comprising them
Grant 11,078,263 - Chiu , et al. August 3, 2 | 2021-08-03 |
Chromatography column qualification in manufacturing methods for producing anti-IL12/IL23 antibody compositions
Grant 11,079,361 - Randolph August 3, 2 | 2021-08-03 |
Serum Albumin-Binding Fibronectin Type III Domains
App 20210228688 - Diem; Michael ; et al. | 2021-07-29 |
Cysteine engineered fibronectin type III domain binding molecules
Grant 11,072,663 - Goldberg , et al. July 27, 2 | 2021-07-27 |
Vaccines Based On Mutant Calr And Jak2 And Their Uses
App 20210222133 - ATTAR; Ricardo ; et al. | 2021-07-22 |
Materials And Methods For In Vivo Biological Targeting
App 20210214440 - Ganesan; Rajkumar ; et al. | 2021-07-15 |
Sustained Response Predictors After Treatment with Anti-IL23 Antibody
App 20210215717 - Munoz; Ernesto ; et al. | 2021-07-15 |
Fused hetero-hetero bicyclic compounds and methods of use thereof
Grant 11,059,819 - Li , et al. July 13, 2 | 2021-07-13 |
EGFR and C-Met Fibronectin Type III Domain Binding Molecules
App 20210206825 - Anderson; Mark ; et al. | 2021-07-08 |
Medical Device for Administering Anti-IL-23 Antibodies
App 20210188966 - Benson; Jacqueline ; et al. | 2021-06-24 |
Methods for the treatment of active Psoriatic Arthritis
Grant 11,041,020 - Harrison , et al. June 22, 2 | 2021-06-22 |
Anti-PHF-Tau Antibodies and Uses Thereof
App 20210179696 - Mercken; Marc ; et al. | 2021-06-17 |
Treatment Of Hidradenitis Suppurativa
App 20210179704 - GIAMARELLOS-BOURBOULIS; Evangelos J. ; et al. | 2021-06-17 |
Method of Treating Psoriasis with Anti-IL23 Specific Antibody
App 20210179703 - Fitzgerald; Dennis ; et al. | 2021-06-17 |
Safe and Effective Method of Treating Ulcerative Colitis with Anti-IL12/IL23 Antibody
App 20210171622 - Johanns; Jewel ; et al. | 2021-06-10 |
Human Antibody Specific For Interleukin-1alpha
App 20210171623 - SIMARD; John | 2021-06-10 |
Differentiation Of Human Embryonic Stem Cells Into Pancreatic Endocrine Cells Using Hb9 Regulators
App 20210171916 - Rezania; Alireza | 2021-06-10 |
Method for Determining Severity of Skin Disease Based on Percentage of Body Surface Area Covered by Lesions
App 20210174512 - Chen; Yanqing ; et al. | 2021-06-10 |
B-cell Maturation Complex Car T Construct And Primers
App 20210164045 - GEORGE; Rebecca ; et al. | 2021-06-03 |
Immune modulation and treatment of solid tumors with antibodies that specifically bind CD38
Grant 11,021,543 - Ahmadi , et al. June 1, 2 | 2021-06-01 |
Cyclic dinucleotides as sting agonists
Grant 11,021,511 - Emanuel , et al. June 1, 2 | 2021-06-01 |
Antibody Fc Mutants with Ablated Effector Functions
App 20210155711 - McCarthy; Stephen ; et al. | 2021-05-27 |
Anti-TNF antibodies, compositions, and methods for the treatment of active ankylosing spondylitis
Grant 11,014,982 - Harrison , et al. May 25, 2 | 2021-05-25 |
Anti-cd79 Chimeric Antigen Receptors, Car-t Cells, And Uses Thereof
App 20210145878 - GANESAN; Rajkumar ; et al. | 2021-05-20 |
Prostate Specific Membrane Antigen Binding Fibronectin Type Iii Domains
App 20210147510 - Cardoso; Rosa ; et al. | 2021-05-20 |
Bcma-targeted Car-t Cell Therapy Of Multiple Myeloma
App 20210128618 - ZUDAIRE UBANI; Enrique | 2021-05-06 |
Methods For Producing Biotherapeutics With Increased Stability By Sequence Optimization
App 20210130440 - Venkataramani; Sathyadevi ; et al. | 2021-05-06 |
Protoxin-II variants and methods of use
Grant 10,995,125 - Flinspach , et al. May 4, 2 | 2021-05-04 |
Antibodies that specifically bind PD-1 and methods of use
Grant 10,995,149 - Chen , et al. May 4, 2 | 2021-05-04 |
Safe and Effective Method of Treating Ulcerative Colitis with Anti-IL12/IL23 Antibody
App 20210115129 - Johanns; Jewel ; et al. | 2021-04-22 |
Subcutaneous Formulations Of Anti-CD38 Antibodies And Their Uses
App 20210107991 - Jansson; Richard ; et al. | 2021-04-15 |
Protoxin-II variants and methods of use
Grant 10,975,129 - Flinspach , et al. April 13, 2 | 2021-04-13 |
Antibodies that Specifically Bind PD-1 and Methods of Use
App 20210102000 - Chen; Qiang ; et al. | 2021-04-08 |
Anti-ceacam Antibodies And Uses Thereof
App 20210095024 - BLACKWELL; Wendell Lamar B ; et al. | 2021-04-01 |
Co-Therapy Comprising A Small Molecule CSF-1R Inhibitor And An Agonistic Antibody That Specifically Binds CD40 For The Treatment Of Cancer
App 20210093719 - Quigley; Michael ; et al. | 2021-04-01 |
Subcutaneous Formulations Of Anti-CD38 Antibodies And Their Uses
App 20210095042 - Jansson; Richard ; et al. | 2021-04-01 |
Methods of treating moderately to severely active ulcerative colitis by administering an anti-IL12/IL23 antibody
Grant 10,961,307 - Johanns , et al. March 30, 2 | 2021-03-30 |
Methods of treatment using human anti-IL-23 antibodies
Grant 10,954,297 - Benson , et al. March 23, 2 | 2021-03-23 |
EGFR and c-Met fibronectin type III domain binding molecules
Grant 10,954,284 - Anderson , et al. March 23, 2 | 2021-03-23 |
Use Of Small Molecules To Enhance Mafa Expression In Pancreatic Endocrine Cells
App 20210079353 - Rezania; Alireza | 2021-03-18 |
Methods Of Treating Renal Cancer With An Anti- Psma/cd3 Antibody
App 20210079115 - McDevitt; Theresa ; et al. | 2021-03-18 |
Differentiation of human embryonic stem cells into pancreatic endocrine cells using thyroid hormone and/or alk5, an inhibitor of tgf-beta type 1 receptor
Grant 10,947,511 - Rezania March 16, 2 | 2021-03-16 |
Method of treating osteoarthritis with human oncostatin M antibodies
Grant 10,941,197 - Almagro , et al. March 9, 2 | 2021-03-09 |
Combination Therapies With Anti-cd38 Antibodies
App 20210061920 - Doshi; Parul | 2021-03-04 |
Serum albumin-binding fibronectin type III domains
Grant 10,925,932 - Diem , et al. February 23, 2 | 2021-02-23 |
Materials And Methods For Improved Single Chain Variable Fragments
App 20210047435 - Luo; Jinquan ; et al. | 2021-02-18 |
Therapeutic Immune Cells With Improved Function And Methods For Making The Same
App 20210047423 - HE; Shan ; et al. | 2021-02-18 |
Anti-CD38 Antibodies for Treatment of Acute Myeloid Leukemia
App 20210047401 - Doshi; Parul ; et al. | 2021-02-18 |
CD137 Binding Fibronectin Type III Domains
App 20210040180 - Diem; Michael ; et al. | 2021-02-11 |
Proteins Comprising Kallikrein Related Peptidase 2 Antigen Binding Domains And Their Uses
App 20210040210 - Ganesan; Rajkumar ; et al. | 2021-02-11 |
Methods Of Treating Prostate Cancer With An Anti- Psma/cd3 Antibody
App 20210040209 - McDevitt; Theresa ; et al. | 2021-02-11 |
CD8A-Binding Fibronectin Type III Domains
App 20210032312 - Hawkins; Rebecca ; et al. | 2021-02-04 |
Materials And Methods For Modulating T Cell Mediated Immunity
App 20210032338 - Ganesan; Rajkumar ; et al. | 2021-02-04 |
Synthetic Genetic Elements For Biomanufacture
App 20210032657 - Perry, III; William Lloyd ; et al. | 2021-02-04 |
Pd-l1 Binding Fibronectin Type Iii Domains
App 20210024612 - Diem; Michael ; et al. | 2021-01-28 |
Human antibody specific for interleukin-1 alpha
Grant 10,899,833 - Simard January 26, 2 | 2021-01-26 |
Radiolabeling Of Polypeptides
App 20210017099 - Dudkin; Vadim ; et al. | 2021-01-21 |
Combination Therapies With Bispecific Anti-EGFR/c-Met Antibodies and Third Generation EGFR Tyrosine Kinase Inhibitors
App 20210017285 - Laquerre; Sylvie ; et al. | 2021-01-21 |
Antibodies specifically binding PD-1, TIM-3 or PD-1 and TIM-3 and their uses
Grant 10,894,830 - Verona , et al. January 19, 2 | 2021-01-19 |
Antibody Fc mutants with ablated effector functions
Grant 10,894,836 - Stephen , et al. January 19, 2 | 2021-01-19 |
Cyclic Dinucleotides As Sting Agonists
App 20210009630 - BEIGELMAN; Leonid ; et al. | 2021-01-14 |
Combination Therapies Comprising Daratumumab, Bortezomib, Thalidomide and Dexamethasone and Their Uses
App 20200405854 - Liu; Xiangyang ; et al. | 2020-12-31 |
Anti-CD38 Antibodies for Treatment of Light Chain Amyloidosis and Other CD38-Positive Hematological Malignancies
App 20200407459 - Chaulagain; Chakra ; et al. | 2020-12-31 |
Combination Therapies Comprising Daratumumab, Bortezomib, Thalidomide and Dexamethasone and Their Uses
App 20200397896 - Liu; Xiangyang ; et al. | 2020-12-24 |
Use of small molecules to enhance MAFA expression in pancreatic endocrine cells
Grant 10,870,832 - Rezania December 22, 2 | 2020-12-22 |
Combination Therapies Comprising Daratumumab, Bortezomib, Thalidomide and Dexamethasone and Their Uses
App 20200392242A1 - | 2020-12-17 |
Novel Aav Mediated Influenza Vaccines
App 20200390888A1 - | 2020-12-17 |
Method of Treating Psoriatic Arthritis with Increased Interval Dosing of Anti-IL12/23 Antibody
App 20200384081A1 - | 2020-12-10 |
Safe and Effective Method of Treating Psoriatic Arthritis with Anti-IL23 Specific Antibody
App 20200385453A1 - | 2020-12-10 |
Safe and Effective Method of Treating Psoriasis with Anti-IL23 Specific Antibody
App 20200385454A1 - | 2020-12-10 |
Co-therapy comprising a small molecule CSF-1R inhibitor and an agonistic antibody that specifically binds CD40 for the treatment of cancer
Grant 10,857,230 - Quigley , et al. December 8, 2 | 2020-12-08 |
Additive channels
Grant 10,852,311 - Levner , et al. December 1, 2 | 2020-12-01 |
Method of Treating Inflammatory Bowel Disease with a Combination Therapy of Antibodies to IL-23 and TNF Alpha
App 20200369761A1 - | 2020-11-26 |
Prostate specific membrane antigen binding fibronectin type III domains
Grant 10,844,111 - Cardoso , et al. November 24, 2 | 2020-11-24 |
Prostate specific membrane antigen (PSMA) bispecific binding agents and uses thereof
Grant 10,844,122 - Anderson , et al. November 24, 2 | 2020-11-24 |
Macrocyclic Chelators and Methods of Use Thereof
App 20200353105A1 - | 2020-11-12 |
Subcutaneous Formulations Of Anti-CD38 Antibodies And Their Uses
App 20200339701A1 - | 2020-10-29 |
Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib, Mephalan and Prednisone
App 20200330593A1 - | 2020-10-22 |
Combination Therapies Comprising Daratumumab, Bortezomib, Thalidomide and Dexamethasone and Their Uses
App 20200330594A1 - | 2020-10-22 |
Immortalized Car-t Cells Genetically Modified To Eliminate T-cell Receptor And Beta 2-microglobulin Expression
App 20200332255A1 - | 2020-10-22 |
Dihydroorotate Dehydrogenase Inhibitors
App 20200331881A1 - | 2020-10-22 |
Method of Treating Psoriasis in Pediatric Subjects with Anti-IL12/IL23 Antibody
App 20200331996A1 - | 2020-10-22 |
Cysteine Engineered Fibronectin Type Iii Domain Binding Molecules
App 20200325210A1 - | 2020-10-15 |
Combination therapies with anti-CD38 antibodies
Grant 10,800,851 - Doshi October 13, 2 | 2020-10-13 |
Anti-HLA-C Antibodies and Uses Thereof
App 20200317791A1 - | 2020-10-08 |
Compositions And Methods For Antibodies Targeting Staphylococcal Leukotoxins
App 20200317758A1 - | 2020-10-08 |
Method of Administration of an Anti-IFN-alpha/-omega Antibody
App 20200317771A1 - | 2020-10-08 |
Anti-cd154 Antibodies And Methods Of Using Them
App 20200317794A1 - | 2020-10-08 |
Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib and Dexamethasone
App 20200316197A1 - | 2020-10-08 |
Anti-CD38 antibodies for treatment of acute myeloid leukemia
Grant 10,793,630 - Doshi , et al. October 6, 2 | 2020-10-06 |
Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Pomalidomide and Dexamethasone
App 20200308296A1 - | 2020-10-01 |
Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Lenalidomide and Dexamethasone
App 20200308284A1 - | 2020-10-01 |
Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses
App 20200308297A1 - | 2020-10-01 |
AAV mediated influenza vaccines
Grant 10,786,568 - Limberis , et al. September 29, 2 | 2020-09-29 |
Compositions and methods for anti-staphylococcal biologic agents
Grant 10,781,246 - Brezski , et al. Sept | 2020-09-22 |
Subcutaneous formulations of anti-CD38 antibodies and their uses
Grant 10,781,261 - Jansson , et al. Sept | 2020-09-22 |
Fibronectin Type Iii Domain Based Scaffold Compositions, Methods And Uses
App 20200291094A1 - | 2020-09-17 |
Manufacturing Methods for Producing Anti-IL12/IL23 Antibody Compositions
App 20200291107A1 - | 2020-09-17 |
Use Of Noggin, An Alk5 Inhibitor And A Protein Kinase C Activator, To Produce Endocrine Cells
App 20200291360A1 - | 2020-09-17 |
Method of treating psoriasis with increased interval dosing of anti-IL12/23 antibody
Grant 10,765,724 - Chevrier , et al. Sep | 2020-09-08 |
Anti-PHF-tau antibodies and uses thereof
Grant 10,766,953 - Mercken , et al. Sep | 2020-09-08 |
Anti-CD38 antibodies for treatment of light chain amyloidosis and other CD38-positive hematological malignancies
Grant 10,766,965 - Chaulagain , et al. Sep | 2020-09-08 |
Human Anti-CD27 Antibodies
App 20200277393A1 - | 2020-09-03 |
Treatment Of Hidradenitis Suppurativa
App 20200277370A1 - | 2020-09-03 |
Interferon alpha and omega antibody antagonists
Grant 10,759,854 - Chi , et al. Sep | 2020-09-01 |
Gamma Delta T Cells And Uses Thereof
App 20200268797A1 - | 2020-08-27 |
Methods of Treating Newly Diagnosed Multiple Myeloma with a Combination of An Antibody that Specifically Binds CD38, Lenalidomide and Dexamethasone
App 20200268847A1 - | 2020-08-27 |
Combination Therapies and Patient Stratification with Bispecific Anti-EGFR/c-Met Antibodies
App 20200270351A1 - | 2020-08-27 |
Combination Therapy For Treatment Of B-Cell Malignancies
App 20200262925A1 - | 2020-08-20 |
GITR antibodies, methods, and uses
Grant 10,730,950 - Holland , et al. | 2020-08-04 |
FC Engineered Anti-TNFR Superfamily Member Antibodies Having Enhanced Atonistic Activity and Methods of Using Them
App 20200231693A1 - | 2020-07-23 |
Gprc5d Chimeric Antigen Receptors And Cells Expressing The Same
App 20200231686A1 - | 2020-07-23 |
Subcutaneous Formulations Of Anti-CD38 Antibodies And Their Uses
App 20200231697A1 - | 2020-07-23 |
Anti-CD38 Antibodies for Treatment of Acute Lymphoblastic Leukemia
App 20200223936A1 - | 2020-07-16 |
Prostate Neoantigens And Their Uses
App 20200222478A1 - | 2020-07-16 |
Use of noggin, an ALK5 inhibitor and a protein kinase c activator to produce endocrine cells
Grant 10,704,025 - Xu | 2020-07-07 |
Generation Of Human Pluripotent Stem Cell Derived Functional Beta Cells Showing A Glucose-dependent Mitochondrial Respiration And Two-phase Insulin Secretion Response
App 20200208116A1 - | 2020-07-02 |
Safe and Effective Method of Treating Lupus with Anti-IL12/IL23 Antibody
App 20200197517A1 - | 2020-06-25 |
Methods of inhibiting naive T-cell proliferation using anti-CD27 antibodies
Grant 10,689,453 - Chen , et al. | 2020-06-23 |
Methods Of Treating Cancers And Enhancing Efficacy Of T Cell Redirecting Therapeutics
App 20200190205A1 - | 2020-06-18 |
Methods of Producing Heterodimeric Antibodies
App 20200190200A1 - | 2020-06-18 |
Drug Mixing Device
App 20200179227A1 - | 2020-06-11 |
Drug Mixing Device
App 20200179225A1 - | 2020-06-11 |
Drug Mixing Device
App 20200170884A1 - | 2020-06-04 |
Methods Of Treating Follicular Lymphoma
App 20200171034A1 - | 2020-06-04 |
Engineered antibodies and other Fc-domain containing molecules with enhanced agonism and effector functions
Grant 10,669,344 - Armstrong , et al. | 2020-06-02 |
Anti-CD154 antibodies and methods of using them
Grant 10,669,343 - Fransson , et al. | 2020-06-02 |
Combination therapies for heme malignancies with anti-CD38 antibodies and survivin inhibitors
Grant 10,668,149 - Doshi , et al. | 2020-06-02 |
Drug Mixing Device
App 20200163834A1 - | 2020-05-28 |
Drug Mixing Device
App 20200163836A1 - | 2020-05-28 |
Drug Mixing Device
App 20200163839A1 - | 2020-05-28 |
Drug Mixing Device
App 20200163840A1 - | 2020-05-28 |
Drug Mixing Device
App 20200163838A1 - | 2020-05-28 |
Cysteine engineered fibronectin type III domain binding molecules
Grant 10,662,235 - Anderson , et al. | 2020-05-26 |
Safe and Effective Method of Treating Psoriasis with Anti-IL-23 Specific Antibody
App 20200157209A1 - | 2020-05-21 |
Fibronectin type III domain based scaffold compositions, methods and uses
Grant 10,654,913 - Jacobs , et al. | 2020-05-19 |
Control of Trace Metals During Production of Anti-CD38 Antibodies
App 20200148782A1 - | 2020-05-14 |
GM-CSF Variants and Methods of Use
App 20200148736A1 - | 2020-05-14 |
Anti-IL-23 Antibodies, Compositions, Methods and Uses
App 20200138943A1 - | 2020-05-07 |
Type I Interferon Signatures and Methods of Use
App 20200131241A1 - | 2020-04-30 |
Methods for production of functional beta cells
Grant 10,633,635 - Rieck , et al. | 2020-04-28 |
Method of Providing Subcutaneous Administration of Anti-CD38 Antibodies
App 20200121588A1 - | 2020-04-23 |
CD8a-binding fibronectin type III domains
Grant 10,626,165 - Hawkins , et al. | 2020-04-21 |
Methods of Suppressing Rheumatoid Arthritis Using an Anti-IL-6 Antibody
App 20200115445A1 - | 2020-04-16 |
CD137 binding fibronectin type III domains
Grant 10,611,823 - Diem , et al. | 2020-04-07 |
Combination therapies with anti-CD38 antibodies
Grant 10,604,580 - Lokhorst , et al. | 2020-03-31 |
Safe and Effective Method of Treating Ulcerative Colitis with Anti-IL12/IL23 Antibody
App 20200095315A1 - | 2020-03-26 |
PD-L1 binding fibronectin type III domains
Grant 10,597,438 - Diem , et al. | 2020-03-24 |
Bispecific EGFR/C-Met Antibodies
App 20200087407A1 - | 2020-03-19 |
Anti-IL-23 antibodies
Grant 10,576,150 - Benson , et al. | 2020-03-03 |
Method for Treating Lupus By Administering An Anti-IL-12 Antibody
App 20200062841A1 - | 2020-02-27 |
Lipase Degradation Resistant Surfactants for Use in Large Molecule Therapeutic Formulations
App 20200061015A1 - | 2020-02-27 |
Fibronectin type III repeat based protein scaffolds with alternative binding surfaces
Grant 10,571,472 - Diem , et al. Feb | 2020-02-25 |
Protoxin-ii Variants And Methods Of Use
App 20200054712A1 - | 2020-02-20 |
Palm Activated Drug Delivery Device
App 20200054838A1 - | 2020-02-20 |
Palm Activated Drug Delivery Device
App 20200054840A1 - | 2020-02-20 |
GM-CSF variants and methods of use
Grant 10,562,948 - Rutkoski , et al. Feb | 2020-02-18 |
Differentiation Of Human Embryonic Stem Cells
App 20200048614A1 - | 2020-02-13 |
Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia
Grant 10,556,961 - Doshi Feb | 2020-02-11 |
Agonistic antibodies specifically binding CD40 and methods of use
Grant 10,544,229 - Fransson , et al. Ja | 2020-01-28 |
Method for treating lupus by administering an anti-IL-12 antibody
Grant 10,519,231 - Giles-Komar , et al. Dec | 2019-12-31 |
Methods of enhancing expression of somatostatin in pancreatic endocrine cells
Grant 10,519,424 - Rezania Dec | 2019-12-31 |
Palm activated drug delivery device
Grant 10,500,348 - Olson , et al. Dec | 2019-12-10 |
Use of a TGF-.beta.R-1 kinase to produce human pancreatic endocrine cells
Grant 10,494,609 - Rezania De | 2019-12-03 |
Palm activated drug delivery device
Grant 10,485,931 - Olson , et al. Nov | 2019-11-26 |
Lowering blood glucose
Grant 10,471,104 - Xu Nov | 2019-11-12 |
Anti-TNF antibodies, compositions, methods and use for the treatment or prevention of type 1 diabetes
Grant 10,465,003 - Hedrick , et al. No | 2019-11-05 |
Protoxin-II variants and methods of use
Grant 10,463,714 - Flinspach , et al. No | 2019-11-05 |
Pancreatic endocrine cells and methods thereof
Grant 10,456,424 - Xu Oc | 2019-10-29 |
ST2L antagonists and methods of use
Grant 10,450,377 - Duffy , et al. Oc | 2019-10-22 |
Methods for making pancreatic endocrine cells
Grant 10,421,948 - Rezania , et al. Sept | 2019-09-24 |
Differentiation of pluripotent stem cells to intestinal midgut endoderm cells
Grant 10,420,803 - Rieck , et al. Sept | 2019-09-24 |
Huwentoxin-IV variants and methods of use
Grant 10,414,808 - Eckert , et al. Sept | 2019-09-17 |
Subcutaneous formulations of anti-CD38 antibodies and their uses
Grant 10,385,135 - Jansson , et al. A | 2019-08-20 |
Methods for suspension cultures of human pluripotent stem cells
Grant 10,377,989 - Fryer , et al. A | 2019-08-13 |
Method for making human pluripotent suspension cultures and cells derived therefrom
Grant 10,370,644 - Fryer , et al. | 2019-08-06 |
Differentiation of human embryonic stem cells into single hormonal insulin positive cells
Grant 10,358,628 - Rezania | 2019-07-23 |
| 